标题
Apoptosis of tumor-infiltrating T lymphocytes: a new immune checkpoint mechanism
作者
关键词
-
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
出版商
Springer Nature America, Inc
发表日期
2018-11-07
DOI
10.1007/s00262-018-2269-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Myeloid-derived suppressor cells coming of age
- (2018) Filippo Veglia et al. NATURE IMMUNOLOGY
- Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells
- (2018) Jie Zhou et al. SEMINARS IN IMMUNOLOGY
- Cancer-associated fibroblasts induce antigen-specific deletion of CD8+ T Cells to protect tumour cells
- (2018) Matthew A. Lakins et al. Nature Communications
- TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis
- (2018) I-Tsu Chyuan et al. Frontiers in Immunology
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- TNFR2: A Novel Target for Cancer Immunotherapy
- (2017) Éva S. Vanamee et al. TRENDS IN MOLECULAR MEDICINE
- Resistance to cancer immunotherapy mediated by apoptosis of tumor-infiltrating lymphocytes
- (2017) Jingjing Zhu et al. Nature Communications
- c-FLIP Expression in Foxp3-Expressing Cells Is Essential for Survival of Regulatory T Cells and Prevention of Autoimmunity
- (2017) Carlos Plaza-Sirvent et al. Cell Reports
- Intratumoral CD8 + T-cell Apoptosis Is a Major Component of T-cell Dysfunction and Impedes Antitumor Immunity
- (2017) Brendan L. Horton et al. Cancer Immunology Research
- CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases
- (2017) Matthieu Le Gallo et al. Frontiers in Immunology
- Selective Targeting of Myeloid-Derived Suppressor Cells in Cancer Patients Using DS-8273a, an Agonistic TRAIL-R2 Antibody
- (2016) George A. Dominguez et al. CLINICAL CANCER RESEARCH
- Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
- (2016) Robert L. Ferris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Human neutrophils: Their role in cancer and relation to myeloid-derived suppressor cells
- (2016) Katrin Moses et al. SEMINARS IN IMMUNOLOGY
- Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
- (2016) Manuela Liguori et al. Oncotarget
- Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
- (2015) Thomas Condamine et al. Annual Review of Medicine
- Neutralization of the CD95 ligand by APG101 inhibits invasion of glioma cells in vitro
- (2015) Christian Merz et al. ANTI-CANCER DRUGS
- Fas Ligand Deficiency Impairs Tumor Immunity by Promoting an Accumulation of Monocytic Myeloid-Derived Suppressor Cells
- (2015) S. Peyvandi et al. CANCER RESEARCH
- CD95 promotes metastatic spread via Sck in pancreatic ductal adenocarcinoma
- (2015) M Teodorczyk et al. CELL DEATH AND DIFFERENTIATION
- Memory T cell–driven differentiation of naive cells impairs adoptive immunotherapy
- (2015) Christopher A. Klebanoff et al. JOURNAL OF CLINICAL INVESTIGATION
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic Melanoma
- (2015) Dirk Schadendorf et al. JOURNAL OF CLINICAL ONCOLOGY
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histone deacetylase inhibitors prevent activation-induced cell death and promote anti-tumor immunity
- (2015) K Cao et al. ONCOGENE
- Functional Tuning of CARs Reveals Signaling Threshold above Which CD8+ CTL Antitumor Potency Is Attenuated due to Cell Fas-FasL-Dependent AICD
- (2015) A. Kunkele et al. Cancer Immunology Research
- A Phase II, Randomized, Study of Weekly APG101+Reirradiation versus Reirradiation in Progressive Glioblastoma
- (2014) W. Wick et al. CLINICAL CANCER RESEARCH
- Human Circulating CD4+CD25highFoxp3+ Regulatory T Cells Kill Autologous CD8+ but Not CD4+ Responder Cells by Fas-Mediated Apoptosis
- (2014) L. Strauss et al. JOURNAL OF IMMUNOLOGY
- Regulatory T Cells and Myeloid-Derived Suppressor Cells in the Tumor Microenvironment Undergo Fas-Dependent Cell Death during IL-2/ CD40 Therapy
- (2014) J. M. Weiss et al. JOURNAL OF IMMUNOLOGY
- Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors
- (2014) Gregory T Motz et al. NATURE MEDICINE
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Death Receptor-Ligand Systems in Cancer, Cell Death, and Inflammation
- (2013) H. Walczak Cold Spring Harbor Perspectives in Biology
- Tumor Endothelial Cells
- (2013) A. C. Dudley Cold Spring Harbor Perspectives in Medicine
- TRAIL suppresses tumor growth in mice by inducing tumor-infiltrating CD4+CD25+ Treg apoptosis
- (2012) Zhijuan Diao et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-associated neutrophils: friend or foe?
- (2012) Z. G. Fridlender et al. CARCINOGENESIS
- Defective cell death signalling along the Bcl-2 regulated apoptosis pathway compromises Treg cell development and limits their functionality in mice
- (2012) Denise Tischner et al. JOURNAL OF AUTOIMMUNITY
- Death Receptor 6 Induces Apoptosis Not through Type I or Type II Pathways, but via a Unique Mitochondria-dependent Pathway by Interacting with Bax Protein
- (2012) Linlin Zeng et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Fas Ligand Enhances Malignant Behavior of Tumor Cells through Interaction with Met, Hepatocyte Growth Factor Receptor, in Lipid Rafts
- (2012) Huan-Ching Lin et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TNF signaling drives myeloid-derived suppressor cell accumulation
- (2012) Xueqiang Zhao et al. JOURNAL OF CLINICAL INVESTIGATION
- Epithelial-Mesenchymal-Transition-Like and TGFβ Pathways Associated with Autochthonous Inflammatory Melanoma Development in Mice
- (2012) Maria Wehbe et al. PLoS One
- Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL
- (2011) P. Sinha et al. BLOOD
- How CD95 stimulates invasion
- (2011) Ernst J.A. Steller et al. CELL CYCLE
- Tumor necrosis factor receptor cross-talk
- (2011) Petrus J. W. Naudé et al. FEBS Journal
- Contrasting effects of TNF and anti-TNF on the activation of effector T cells and regulatory T cells in autoimmunity
- (2011) Xin Chen et al. FEBS LETTERS
- Cytotoxic T lymphocyte perforin and Fas ligand working in concert even when Fas ligand lytic action is still not detectable
- (2011) David Hassin et al. IMMUNOLOGY
- The Adaptor Protein TRADD Is Essential for TNF-Like Ligand 1A/Death Receptor 3 Signaling
- (2011) Y. L. Pobezinskaya et al. JOURNAL OF IMMUNOLOGY
- Tumor-Initiated Inflammation Overrides Protective Adaptive Immunity in an Induced Melanoma Model in Mice
- (2010) Saïdi M. Soudja et al. CANCER RESEARCH
- Bcl-2-regulated cell death signalling in the prevention of autoimmunity
- (2010) D Tischner et al. Cell Death & Disease
- Non-apoptotic Fas signaling regulates invasiveness of glioma cells and modulates MMP-2 activity via NFκB-TIMP-2 pathway
- (2009) Pawel Wisniewski et al. CELLULAR SIGNALLING
- Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
- (2009) Lorraine A. O’ Reilly et al. NATURE
- Adoptively transferred effector cells derived from naive rather than central memory CD8+ T cells mediate superior antitumor immunity
- (2009) C. S. Hinrichs et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Plasminogen Activator Inhibitor-1 Protects Endothelial Cells from FasL-Mediated Apoptosis
- (2008) Khalid Bajou et al. CANCER CELL
- Yes and PI3K Bind CD95 to Signal Invasion of Glioblastoma
- (2008) Susanne Kleber et al. CANCER CELL
- Blocking TNF-α in mice reduces colorectal carcinogenesis associated with chronic colitis
- (2008) Boryana K. Popivanova et al. JOURNAL OF CLINICAL INVESTIGATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now